China’s Supreme People’s Court consults on evidence admissibility in patent validity proceedings
We spoke to lawyers in China to ask what the guidelines mean for patent litigation, especially in chemical/pharmaceutical cases
The Supreme People’s Court (SPC)
is consulting on a draft judicial interpretation on
evidence admissibility in patent validity proceedings.
Following the permission of post-filing experimental data by
China’s patent office, the guidelines help to
clarify what the best practices are to ensure...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.